Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.
D000577:Amides / Q000494:pharmacology; D000818:Animals; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000494:pharmacology; D002460:Cell Line; D002860:Chromium Radioisotopes; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006648:Histocompatibility; D007093:Imidazoles / Q000494:pharmacology; D007111:Immunity, Cellular / Q000187:drug effects*; D007939:Leukemia L1210 / Q000276:immunology*; D008214:Lymphocytes / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D013154:Spleen / Q000166:cytology / Q000276:immunology; D014184:Transplantation, Homologous; D014226:Triazenes / Q000494:pharmacology
D000577:Amides; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002860:Chromium Radioisotopes; D007093:Imidazoles; D014226:Triazenes